Gemcitabine and acute myocardial infarction: A case report

Angiology

Volumn 57, Issue 3, 2006, Pages 367-371

  Bdair, Fadi M ^a   Graham, Susan P ^a   Smith, Patrick F ^b   Javle, Milind M ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORIDE; CHOLESTEROL; CREATINE KINASE; CREATINE KINASE MB; CREATININE; DIGOXIN; DOCETAXEL; EPTIFIBATIDE; ESCITALOPRAM; GABAPENTIN; GEFITINIB; GEMCITABINE; GLYCERYL TRINITRATE; HEPARIN; INTEGRILLIN; LOW DENSITY LIPOPROTEIN; NIFEDIPINE; NITRIC ACID DERIVATIVE; NITROGEN; POTASSIUM; RABEPRAZOLE; ROFECOXIB; SODIUM; SPIRONOLACTONE; TROPONIN I; UNINDEXED DRUG; UREA; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; QUINAZOLINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE; CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CASE REPORT; CONGESTIVE HEART FAILURE; CONVALESCENCE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; LUNG NON SMALL CELL CANCER; METASTASIS; MONOTHERAPY; MYOCARDITIS; NAUSEA; PERICARDITIS; Q WAVE; SIDE EFFECT; THORAX PAIN; THROMBOSIS; VOMITING; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; HEART INFARCTION; LUNG TUMOR; PATHOLOGY; REVIEW;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; MYOCARDIAL INFARCTION; NEOPLASM METASTASIS; QUINAZOLINES;

EID: 33745527526     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970605700314     Document Type: Article

References (20)

1. Physician's Desk Reference (PDR) https://www.pdr.net/pdrnet/librarian (accessed February 2, 2003).
2. Pai VB, Nahata MC: Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention (review). Drug Saf 22:263-302, 2000.
3. Labianca R, Beretta G, Clerici M, et al: Cardiac toxicity of 5-fluorouracil: A study on 1083 patients. Tumori 68:505-510, 1982.
4. May D, Wandl U, Becher R, et al: [Cardiac side effects of 5-fluorouracil.] [German]. Deutsche Medizinische Wochenschrift 115:618-621, 1990.
5. Patel B, Kloner RA, Ensley J, et al: 5-Fluorouracil cardiotoxicity: Left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 294:238-243, 1987.
6. Mandel EM, Lewinski U, Djaldetti M: Vincristine-induced myocardial infarction. Cancer 36:1979-1982, 1975.
7. Subar M, Muggia FM: Apparent myocardial ischemia associated with vinblastine administration. Cancer Treat Rep 70:690-691, 1986.
8. Vogelzang NJ, Frenning DH, Kennedy BJ: Coronary artery disease after treatment with bleomycin and vinblastine. Cancer Treat Rep 64:1159-1160, 1980.
9. Somers G, Abramov M, Witter M, et al: Myocardial infarction: A complication of vincristine treatment? (letter). Lancet 2:690, 1976.
10. Grem JL, King SA, Chun HG, et al: Cardiac complications observed in elderly patients following 2′-deoxycoformycin therapy. Am J Hematol 38:245-247, 1991.
11. Arbuck SG, Strauss H, Rowinsky E, et al: A reassessment of cardiac toxicity associated with Taxol (review). J Natl Cancer Inst Monographs 15:117-130, 1993.
12. Schwarzer S, Eber B, Greinix H, et al: Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy. Eur Heart J 12:748-750, 1991.
13. Airey CL, Dodwell DJ, Joffe JK, et al: Etoposide-related myocardial infarction. Clin Oncol 7:135, 1995.
14. Fragasso G, Pastore MR, Vicari A, et al: Myocardial infarction in a patient with acute lymphoblastic leukemia during L-asparaginase therapy. Am J Hematol 48:136-137, 1995.
15. Kalapura T, Krishnamurthy M, Reddy CV: Acute myocardial infarction following gemcitabine therapy - a case report. Angiology 50:1021-1025, 1999.
16. Lemaire L, Malet-Martino MC, De Forni M, et al: Cardiotoxicity of commercial 5-fluorouracil vial stems from the alkaline hydrolysis of the drug. Br J Cancer 66:119-127, 1992.
17. Dumontet C, Morschhauser F, Solal-Celigny P, et al: Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma. Br J Hematol 113:772-778, 2001.
18. Brand R, Capadano M, Tempero M: A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors. Invest New Drugs 15:331-341, 1997.
19. De Forni M, Malet-Martino MC, Jaillais P, et al: Cardiotoxicity of high-dose continuous infusion fluorouracil: A prospective clinical study. J Clin Oncol 10:1795-1801, 1992.
20. Naranjo CA, Busto U, Sellers EM, et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245, 1981.